Literature DB >> 22859521

Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease.

M Ashworth Dirac1, Kathleen L Horan, David R Doody, J Scott Meschke, David R Park, Lisa A Jackson, Noel S Weiss, Kevin L Winthrop, Gerard A Cangelosi.   

Abstract

RATIONALE: Mycobacterium avium complex lung disease is an increasingly common and chronically debilitating problem. Several host traits have been suggested or confirmed as risk factors. Potential environmental and behavioral risk factors have also been proposed. Few have been evaluated in comparative studies.
OBJECTIVES: To determine if aerosol-generating activities in the home and garden, features of the home water supply, or several pulmonary and immune-compromising conditions are associated with Mycobacterium avium complex lung disease.
METHODS: Cases were recruited from academic medical centers and by informal referrals from nonuniversity practices in Washington and Oregon. Control subjects were recruited by random-digit dialing and matched to cases by age, sex, and partial telephone number. Associations were measured as odds ratios (OR) estimated using conditional logistic regression.
MEASUREMENTS AND MAIN RESULTS: Known and potential risk factors were measured by in-home interview. Fifty-two matched pairs were studied. Six of 12 examined host traits were associated with disease, including history of chronic obstructive pulmonary disease (OR, 10; 95% confidence interval [CI], 1.2-80), pneumonia hospitalization (OR, 3.4; 95% CI, 1.1-11), and steroid use (OR, 8; 95% CI, 1.6-41). In contrast, 11 of the 14 aerosol-generating activities and all five features of home water supply studied bore little or no association with disease.
CONCLUSIONS: Aerosol-generating activities seem not to be risk factors for Mycobacterium avium complex lung disease in HIV-negative adults, but prior lung disease and immune-suppressing drugs seem to be associated with susceptibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859521      PMCID: PMC5450977          DOI: 10.1164/rccm.201205-0825OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Aerosol mapping of a facility with multiple cases of hypersensitivity pneumonitis: demonstration of mist reduction and a possible dose/response relationship.

Authors:  Dennis M O'Brien
Journal:  Appl Occup Environ Hyg       Date:  2003-11

3.  Nontuberculous mycobacteria in aerosol droplets and bulk water samples from therapy pools and hot tubs.

Authors:  Craig S Glazer; John W Martyny; Ben Lee; Tracy L Sanchez; Tricia M Sells; Lee S Newman; James Murphy; Leonid Heifets; Cecile S Rose
Journal:  J Occup Environ Hyg       Date:  2007-11       Impact factor: 2.155

4.  Epidemiology of infection by nontuberculous mycobacteria. II. Growth and survival in natural waters.

Authors:  K L George; B C Parker; H Gruft; J O Falkinham
Journal:  Am Rev Respir Dis       Date:  1980-07

5.  Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245.

Authors:  J Bauer; A B Andersen; D Askgaard; S B Giese; B Larsen
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Mycobacterium avium in a shower linked to pulmonary disease.

Authors:  Joseph O Falkinham; Michael D Iseman; Petra de Haas; Dick van Soolingen
Journal:  J Water Health       Date:  2008-06       Impact factor: 1.744

7.  Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006.

Authors:  Jonathan E Moore; Michelle E Kruijshaar; L Peter Ormerod; Francis Drobniewski; Ibrahim Abubakar
Journal:  BMC Public Health       Date:  2010-10-15       Impact factor: 3.295

8.  Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

Authors:  Richard D Kim; David E Greenberg; Mary E Ehrmantraut; Shireen V Guide; Li Ding; Yvonne Shea; Margaret R Brown; Milica Chernick; Wendy K Steagall; Connie G Glasgow; JingPing Lin; Clara Jolley; Lynn Sorbara; Mark Raffeld; Suvimol Hill; Nilo Avila; Vandana Sachdev; Lisa A Barnhart; Victoria L Anderson; Reginald Claypool; Dianne M Hilligoss; Mary Garofalo; Alan Fitzgerald; Sandra Anaya-O'Brien; Dirk Darnell; Rosamma DeCastro; Heather M Menning; Stacy M Ricklefs; Stephen F Porcella; Kenneth N Olivier; Joel Moss; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

9.  Effect of questionnaire design on recall of drug exposure in pregnancy.

Authors:  A A Mitchell; L B Cottler; S Shapiro
Journal:  Am J Epidemiol       Date:  1986-04       Impact factor: 4.897

10.  Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease.

Authors:  Rachel M Thomson; John G Armstrong; David F Looke
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

View more
  41 in total

Review 1.  Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.

Authors:  Kevin L Winthrop; Michael Iseman
Journal:  Nat Rev Rheumatol       Date:  2013-06-25       Impact factor: 20.543

2.  Association between Inhaled Corticosteroid Use and Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Vincent X Liu; Kevin L Winthrop; Yun Lu; Husham Sharifi; Hekmat U Nasiri; Stephen J Ruoss
Journal:  Ann Am Thorac Soc       Date:  2018-10

3.  Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.

Authors:  D Rebecca Prevots; Jennifer Adjemian; Aisling G Fernandez; Michael R Knowles; Kenneth N Olivier
Journal:  Ann Am Thorac Soc       Date:  2014-09

4.  Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Authors:  Eva P Szymanski; Janice M Leung; Cedar J Fowler; Carissa Haney; Amy P Hsu; Fei Chen; Priya Duggal; Andrew J Oler; Ryan McCormack; Eckhard Podack; Rebecca A Drummond; Michail S Lionakis; Sarah K Browne; D Rebecca Prevots; Michael Knowles; Gary Cutting; Xinyue Liu; Scott E Devine; Claire M Fraser; Hervé Tettelin; Kenneth N Olivier; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

5.  A Geospatial Epidemiologic Analysis of Nontuberculous Mycobacterial Infection: An Ecological Study in Colorado.

Authors:  Ettie M Lipner; David Knox; Joshua French; Jordan Rudman; Michael Strong; James L Crooks
Journal:  Ann Am Thorac Soc       Date:  2017-10

6.  Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.

Authors:  Emily Henkle; Timothy Aksamit; Alan Barker; Charles L Daley; David Griffith; Philip Leitman; Amy Leitman; Elisha Malanga; Theodore K Marras; Kenneth N Olivier; D Rebecca Prevots; Delia Prieto; Alexandra L Quittner; William Skach; John W Walsh; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2016-09

Review 7.  Infection Risk and Safety of Corticosteroid Use.

Authors:  Jameel Youssef; Shannon A Novosad; Kevin L Winthrop
Journal:  Rheum Dis Clin North Am       Date:  2015-10-24       Impact factor: 2.670

8.  Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium.

Authors:  Cedar J Fowler; Kenneth N Olivier; Janice M Leung; Caroline C Smith; Andrea G Huth; Heather Root; Douglas B Kuhns; Carolea Logun; Adrian Zelazny; Cathleen A Frein; Janine Daub; Carissa Haney; James H Shelhamer; Clare E Bryant; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2013-06-15       Impact factor: 21.405

9.  The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.

Authors:  Sara E Strollo; Jennifer Adjemian; Michael K Adjemian; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2015-10

Review 10.  Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights.

Authors:  Pamela J McShane; Jeffrey Glassroth
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.